Suppr超能文献

白藜芦醇、雷帕霉素和二甲双胍作为抗病毒途径的调节剂。

Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways.

作者信息

Benedetti Francesca, Sorrenti Vincenzo, Buriani Alessandro, Fortinguerra Stefano, Scapagnini Giovanni, Zella Davide

机构信息

Institute of Human Virology, Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padova, Italy.

出版信息

Viruses. 2020 Dec 17;12(12):1458. doi: 10.3390/v12121458.

Abstract

Balanced nutrition and appropriate dietary interventions are fundamental in the prevention and management of viral infections. Additionally, accurate modulation of the inflammatory response is necessary to achieve an adequate antiviral immune response. Many studies, both in vitro with mammalian cells and in vivo with small animal models, have highlighted the antiviral properties of resveratrol, rapamycin and metformin. The current review outlines the mechanisms of action of these three important compounds on the cellular pathways involved with viral replication and the mechanisms of virus-related diseases, as well as the current status of their clinical use.

摘要

均衡营养和适当的饮食干预在病毒感染的预防和管理中至关重要。此外,准确调节炎症反应对于实现充分的抗病毒免疫反应是必要的。许多研究,包括在体外对哺乳动物细胞以及在体内对小动物模型进行的研究,都突出了白藜芦醇、雷帕霉素和二甲双胍的抗病毒特性。本综述概述了这三种重要化合物对与病毒复制相关的细胞途径及病毒相关疾病机制的作用机制,以及它们的临床应用现状。

相似文献

1
Resveratrol, Rapamycin and Metformin as Modulators of Antiviral Pathways.
Viruses. 2020 Dec 17;12(12):1458. doi: 10.3390/v12121458.
2
Nutritional reprogramming of mouse liver proteome is dampened by metformin, resveratrol, and rapamycin.
Cell Metab. 2021 Dec 7;33(12):2367-2379.e4. doi: 10.1016/j.cmet.2021.10.016. Epub 2021 Nov 11.
3
Antiviral activity of resveratrol.
Biochem Soc Trans. 2010 Feb;38(Pt 1):50-3. doi: 10.1042/BST0380050.
4
Therapeutic potential of resveratrol against emerging respiratory viral infections.
Pharmacol Ther. 2020 Oct;214:107613. doi: 10.1016/j.pharmthera.2020.107613. Epub 2020 Jun 17.
7
Viral infections and sphingolipids.
Handb Exp Pharmacol. 2013(216):321-40. doi: 10.1007/978-3-7091-1511-4_16.
8
mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3.
Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10069-E10078. doi: 10.1073/pnas.1811892115. Epub 2018 Oct 9.
9
Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis.
Antiviral Res. 2017 Jul;143:162-175. doi: 10.1016/j.antiviral.2017.04.011. Epub 2017 Apr 23.
10
HSP90: a promising broad-spectrum antiviral drug target.
Arch Virol. 2017 Nov;162(11):3269-3282. doi: 10.1007/s00705-017-3511-1. Epub 2017 Aug 5.

引用本文的文献

1
Metformin in Antiviral Therapy: Evidence and Perspectives.
Viruses. 2024 Dec 18;16(12):1938. doi: 10.3390/v16121938.
2
Resveratrol inhibits rabies virus infection in N2a cells by activating the SIRT1/Nrf2/HO-1 pathway.
Heliyon. 2024 Aug 22;10(17):e36494. doi: 10.1016/j.heliyon.2024.e36494. eCollection 2024 Sep 15.
3
The Role of the Nrf2 Pathway in Airway Tissue Damage Due to Viral Respiratory Infections.
Int J Mol Sci. 2024 Jun 27;25(13):7042. doi: 10.3390/ijms25137042.
5
Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines.
J Nanobiotechnology. 2023 Nov 29;21(1):456. doi: 10.1186/s12951-023-02165-x.
8
Resveratrol and Curcumin for Chagas Disease Treatment-A Systematic Review.
Pharmaceuticals (Basel). 2022 May 15;15(5):609. doi: 10.3390/ph15050609.
9
Resveratrol in Intestinal Health and Disease: Focusing on Intestinal Barrier.
Front Nutr. 2022 Mar 16;9:848400. doi: 10.3389/fnut.2022.848400. eCollection 2022.
10
The potential role of resveratrol as supportive antiviral in treating conditions such as COVID-19 - A formulator's perspective.
Biomed Pharmacother. 2022 Apr;148:112767. doi: 10.1016/j.biopha.2022.112767. Epub 2022 Feb 28.

本文引用的文献

1
Anti-HIV Activity of Standard Combined Antiretroviral Therapy in Primary Cells Is Intensified by CCR5-Targeting Drugs.
AIDS Res Hum Retroviruses. 2020 Oct;36(10):835-841. doi: 10.1089/AID.2020.0064. Epub 2020 Aug 3.
2
A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19.
Diabetes Res Clin Pract. 2020 Sep;167:108282. doi: 10.1016/j.diabres.2020.108282. Epub 2020 Jun 25.
3
Therapeutic potential of resveratrol against emerging respiratory viral infections.
Pharmacol Ther. 2020 Oct;214:107613. doi: 10.1016/j.pharmthera.2020.107613. Epub 2020 Jun 17.
5
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Cell. 2020 May 28;181(5):1036-1045.e9. doi: 10.1016/j.cell.2020.04.026. Epub 2020 May 15.
6
Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.
Int J Clin Pract. 2020 Sep;74(9):e13535. doi: 10.1111/ijcp.13535. Epub 2020 Jun 12.
7
Metformin and COVID-19: A novel deal of an old drug.
J Med Virol. 2020 Nov;92(11):2293-2294. doi: 10.1002/jmv.25958. Epub 2020 Jun 3.
8
Biological plausibility for interactions between dietary fat, resveratrol, , and SARS-CoV illness severity.
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E830-E833. doi: 10.1152/ajpendo.00150.2020. Epub 2020 Apr 20.
10
Metformin: current clinical applications in nondiabetic patients with cancer.
Aging (Albany NY). 2020 Feb 18;12(4):3993-4009. doi: 10.18632/aging.102787.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验